StonvexLoading…
StonvexStonvexStonvexCore line items from DCOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.91M | $16.73M | $16.44M | $16.21M |
Operating Income | $156.80M | $51.44M | $136.88M | $211.91M |
Net Income | $110.68M | $29.08M | $96.09M | $152.56M |
EPS (Diluted) | $2.36 | $0.55 | $2.29 | $3.73 |
Total Assets | $15.34B | $14.35B | $13.64B | $13.19B |
Total Liabilities | $13.87B | $12.96B | $12.41B | $12.02B |
Cash & Equivalents | $2.35B | $1.28B | $457.55M | $169.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $291.43M |
Shares Outstanding | 43.86M | 43.62M | 38.82M | 38.57M |